Supreme Court set to consider cert. petition on generic drug use of “skinny labels” to avoid infringing method of use patents. Court expected to consider cert. petition during court conference on May ...

The U.S. Court of Appeals for the Federal Circuit sided with a jury’s 2017 finding that Teva swayed doctors away from using GlaxoSmithKline’s drug Coreg (carvedilol) for a use of its drug that was ...

The federal government re-ignited a controversial proposal to give generic drug makers the power to unilaterally update product labels to reflect new safety information, a proposal that drew criticism ...

The Alabama Supreme Court recently reaffirmed that patients are allowed to sue drug makers who mislead doctors into believing that prescription medicines the companies market do not cause harmful side ...

For the third time, the FDA has delayed a rule requiring generic-drug companies to update product labels if they receive new safety information. To the dismay of patient advocates and the pleasure of ...